Epigenetic Programming and Risk: The Birthplace of Cardiovascular Disease?

Stem Cell Reviews and Reports

Volumn 9, Issue 3, 2013, Pages 241-253

  Vinci, Maria Cristina ^a   Polvani, Gianluca ^b   Pesce, Maurizio ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cardiovascular disease; Developmental plasticity; Differentiation; Epigenetic programming; Metabolic memory; Nutriepigenomics; Stem cells

Indexed keywords

HISTONE;

ARTICLE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOLOGY; DNA METHYLATION; EMBRYO DEVELOPMENT; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; PROTEIN PROCESSING; STEM CELL;

CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; EMBRYONIC DEVELOPMENT; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONES; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; STEM CELLS;

EID: 84878985489     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-012-9398-z     Document Type: Article

References (165)

1. Waddington, C. H. (2012). The epigenotype. 1942. International Journal of Epidemiology, 41, 10-13.
2. Bird, A. (2007). Perceptions of epigenetics. Nature, 447, 396-398.
3. Goldberg, A. D., Allis, C. D., & Bernstein, E. (2007). Epigenetics: a landscape takes shape. Cell, 128, 635-638.
4. Jaenisch, R., & Bird, A. (2003). Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genetics, 33(Suppl), 245-254.
5. Hochberg, Z., Feil, R., Constancia, M., et al. (2011). Child health, developmental plasticity, and epigenetic programming. Endocrine Reviews, 32, 159-224.
6. Medzhitov, R., & Horng, T. (2009). Transcriptional control of the inflammatory response. Nature Reviews Immunology, 9, 692-703.
7. Sharma, S., Kelly, T. K., & Jones, P. A. (2010). Epigenetics in cancer. Carcinogenesis, 31, 27-36.
8. Urdinguio, R. G., Sanchez-Mut, J. V., & Esteller, M. (2009). Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurology, 8, 1056-1072.
9. Barker, D. J. (2002). Fetal programming of coronary heart disease. Trends in Endocrinology and Metabolism, 13, 364-368.
10. Alkemade, F. E., Gittenberger-de Groot, A. C., Schiel, A. E., et al. (2007). Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 2228-2235.
11. Vincent, A., & van Seuningen, I. (2009). Epigenetics, stem cells and epithelial cell fate. Differentiation, 78, 99-107.
12. Robertson, K. D. (2005). DNA methylation and human disease. Nature Reviews Genetics, 6, 597-610.
13. Kouzarides, T. (2007). Chromatin modifications and their function. Cell, 128, 693-705.
14. Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes & Development, 16, 6-21.
15. Prokhortchouk, E., & Defossez, P. A. (2008). The cell biology of DNA methylation in mammals. Biochimica et Biophysica Acta, 1783, 2167-2173.
16. Law, J. A., & Jacobsen, S. E. (2010). Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nature Reviews Genetics, 11, 204-220.
17. Cheng, X., & Roberts, R. J. (2001). AdoMet-dependent methylation, DNA methyltransferases and base flipping. Nucleic Acids Research, 29, 3784-3795.
18. Klimasauskas, S., Kumar, S., Roberts, R. J., et al. (1994). HhaI methyltransferase flips its target base out of the DNA helix. Cell, 76, 357-369.
19. Robertson, K. D. (2002). DNA methylation and chromatin - unraveling the tangled web. Oncogene, 21, 5361-5379.
20. Hata, K., Okano, M., Lei, H., et al. (2002). Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development, 129, 1983-1993.
21. Kareta, M. S., Botello, Z. M., Ennis, J. J., et al. (2006). Reconstitution and mechanism of the stimulation of de novo methylation by human DNMT3L. Journal of Biological Chemistry, 281, 25893-25902.
22. Okano, M., Xie, S., & Li, E. (1998). Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genetics, 19, 219-220.
23. Weber, M., Hellmann, I., Stadler, M. B., et al. (2007). Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nature Genetics, 39, 457-466.
24. Appanah, R., Dickerson, D. R., Goyal, P., et al. (2007). An unmethylated 3′ promoter-proximal region is required for efficient transcription initiation. PLoS Genetics, 3, e27.
25. Ciccone, D. N., Su, H., Hevi, S., et al. (2009). KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature, 461, 415-418.
26. Ooi, S. K., Qiu, C., Bernstein, E., et al. (2007). DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature, 448, 714-717.
27. Klose, R. J., & Bird, A. P. (2006). Genomic DNA methylation: the mark and its mediators. Trends in Biochemical Sciences, 31, 89-97.
28. Hoffman, A. R., & Hu, J. F. (2006). Directing DNA methylation to inhibit gene expression. Cellular and Molecular Neurobiology, 26, 425-438.
29. Hellman, A., & Chess, A. (2007). Gene body-specific methylation on the active X chromosome. Science, 315, 1141-1143.
30. Sapienza, C., Peterson, A. C., Rossant, J., et al. (1987). Degree of methylation of transgenes is dependent on gamete of origin. Nature, 328, 251-254.
31. Reik, W., Collick, A., Norris, M. L., et al. (1987). Genomic imprinting determines methylation of parental alleles in transgenic mice. Nature, 328, 248-251.
32. Reik, W., Howlett, S. K., Surani, M. A. (1990). Imprinting by DNA methylation: from transgenes to endogenous gene sequences. Dev Suppl, 99-106.
33. Pesce, M., Gross, M. K., & Scholer, H. R. (1998). In line with our ancestors: Oct-4 and the mammalian germ. Bioessays, 20, 722-732.
34. Ito, S., D'Alessio, A. C., Taranova, O. V., et al. (2010). Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature, 466, 1129-1133.
35. Popp, C., Dean, W., Feng, S., et al. (2010). Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature, 463, 1101-1105.
36. Hajkova, P., Jeffries, S. J., Lee, C., et al. (2010). Genome-wide reprogramming in the mouse germ line entails the base excision repair pathway. Science, 329, 78-82.
37. Kim, M. S., Kondo, T., Takada, I., et al. (2009). DNA demethylation in hormone-induced transcriptional derepression. Nature, 461, 1007-1012.
38. Morgan, H. D., Dean, W., Coker, H. A., et al. (2004). Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. Journal of Biological Chemistry, 279, 52353-52360.
39. Kangaspeska, S., Stride, B., Metivier, R., et al. (2008). Transient cyclical methylation of promoter DNA. Nature, 452, 112-U114.
40. Wu, H., & Zhang, Y. (2011). Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes & Development, 25, 2436-2452.
41. Bhutani, N., Burns, D. M., & Blau, H. M. (2011). DNA demethylation dynamics. Cell, 146, 866-872.
42. Williams, K., Christensen, J., & Helin, K. (2012). DNA methylation: TET proteins-guardians of CpG islands? EMBO Reports, 13, 28-35.
43. Luger, K., Mader, A. W., Richmond, R. K., et al. (1997). Crystal structure of the nucleosome core particle at 2. 8 A resolution. Nature, 389, 251-260.
44. Martin, C., & Zhang, Y. (2005). The diverse functions of histone lysine methylation. Nature Reviews Molecular Cell Biology, 6, 838-849.
45. Zhang, Y., Fang, H., Jiao, J., et al. (2008). The structure and function of histone deacetylases: the target for anti-cancer therapy. Current Medicinal Chemistry, 15, 2840-2849.
46. Yang, X. J., & Seto, E. (2008). The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nature Reviews Molecular Cell Biology, 9, 206-218.
47. Schuettengruber, B., Chourrout, D., Vervoort, M., et al. (2007). Genome regulation by polycomb and trithorax proteins. Cell, 128, 735-745.
48. Tsukada, Y., Fang, J., Erdjument-Bromage, H., et al. (2006). Histone demethylation by a family of JmjC domain-containing proteins. Nature, 439, 811-816.
49. Warner, M. J., & Ozanne, S. E. (2010). Mechanisms involved in the developmental programming of adulthood disease. Biochemical Journal, 427, 333-347.
50. Kawasaki, H., Taira, K., & Morris, K. V. (2005). siRNA induced transcriptional gene silencing in mammalian cells. Cell Cycle, 4, 442-448.
51. Thambirajah, A. A., Li, A., Ishibashi, T., et al. (2009). New developments in post-translational modifications and functions of histone H2A variants. Biochemistry and Cell Biology / Biochimie et Biologie Cellulaire, 87, 7-17.
52. Ponting, C. P., Oliver, P. L., & Reik, W. (2009). Evolution and functions of long noncoding RNAs. Cell, 136, 629-641.
53. Fabian, M. R., Sonenberg, N., & Filipowicz, W. (2010). Regulation of mRNA translation and stability by microRNAs. Annual Review of Biochemistry, 79, 351-379.
54. Siomi, H., & Siomi, M. C. (2009). On the road to reading the RNA-interference code. Nature, 457, 396-404.
55. Brennecke, J., Aravin, A. A., Stark, A., et al. (2007). Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. Cell, 128, 1089-1103.
56. Hutvagner, G., & Zamore, P. D. (2002). A microRNA in a multiple-turnover RNAi enzyme complex. Science, 297, 2056-2060.
57. Morris, K. V., Chan, S. W., Jacobsen, S. E., et al. (2004). Small interfering RNA-induced transcriptional gene silencing in human cells. Science, 305, 1289-1292.
58. Benetti, R., Gonzalo, S., Jaco, I., et al. (2008). A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nature Structural and Molecular Biology, 15, 998.
59. Carninci, P., Kasukawa, T., Katayama, S., et al. (2005). The transcriptional landscape of the mammalian genome. Science, 309, 1559-1563.
60. Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009). Long non-coding RNAs: insights into functions. Nature Reviews Genetics, 10, 155-159.
61. Khalil, A. M., Guttman, M., Huarte, M., et al. (2009). Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proceedings of the National Academy of Sciences of the United States of America, 106, 11667-11672.
62. Guttman, M., Amit, I., Garber, M., et al. (2009). Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature, 458, 223-227.
63. Ferguson, J. E., Kelley, R. W., & Patterson, C. (2005). Mechanisms of endothelial differentiation in embryonic vasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 2246-2254.
64. Jin, S. W., & Patterson, C. (2009). The opening act vasculogenesis and the origins of circulation. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 623-629.
65. Li, M., Marin-Muller, C., Bharadwaj, U., et al. (2009). MicroRNAs: control and loss of control in human physiology and disease. World Journal of Surgery, 33, 667-684.
66. Fujimoto, T., Ogawa, M., Minegishi, N., et al. (2001). Step-wise divergence of primitive and definitive haematopoietic and endothelial cell lineages during embryonic stem cell differentiation. Genes to Cells, 6, 1113-1127.
67. Lindsley, R. C., Gill, J. G., Kyba, M., et al. (2006). Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm. Development, 133, 3787-3796.
68. Choi, K., Kennedy, M., Kazarov, A., et al. (1998). A common precursor for hematopoietic and endothelial cells. Development, 125, 725-732.
69. Vodyanik, M. A., Bork, J. A., Thomson, J. A., et al. (2005). Human embryonic stem cell-derived CD34(+) cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood, 105, 617-626.
70. Hanze, J., Weissmann, N., Grimminger, F., et al. (2007). Cellular and molecular mechanisms of hypoxia-inducible factor driven vascular remodeling. Thrombosis and Haemostasis, 97, 774-787.
71. Ramirez-Bergeron, D. L., Runge, A., Adelman, D. M., et al. (2006). HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature. Developmental Cell, 11, 81-92.
72. Hosseinkhani, M., Hasegawa, K., Ono, K., et al. (2007). Trichostatin A induces myocardial differentiation of monkey ES cells. Biochemical and Biophysical Research Communications, 356, 386-391.
73. Bendinelli, P., Matteucci, E., Maroni, P., et al. (2009). NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells. Molecular Cancer Research, 7, 1328-1341.
74. Maltepe, E., Krampitz, G. W., Okazaki, K. M., et al. (2005). Hypoxia-inducible factor-dependent histone deacetylase activity determines stem cell fate in the placenta. Development, 132, 3393-3403.
75. Rossig, L., Urbich, C., Bruhl, T., et al. (2005). Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. The Journal of Experimental Medicine, 201, 1825-1835.
76. Rossig, L., Huige, L., Fisslthaler, B., et al. (2002). Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis. Circulation Research, 91, 837-844.
77. Michaelis, M., Michaelis, U. R., Fleming, I., et al. (2004). Valproic acid inhibits angiogenesis in vitro and in vivo. Molecular Pharmacology, 65, 520-527.
78. Gan, Y., Shen, Y. H., Utama, B., et al. (2006). Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells. Biochemical and Biophysical Research Communications, 340, 29-34.
79. Fish, J. E., Matouk, C. C., Rachlis, A., et al. (2005). The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. Journal of Biological Chemistry, 280, 24824-24838.
80. Banerjee, S., & Bacanamwo, M. (2010). DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells. Experimental Cell Research, 316, 172-180.
81. Spallotta, F., Rosati, J., Straino, S., et al. (2010). Nitric oxide determines mesodermic differentiation of mouse embryonic stem cells by activating class IIa histone deacetylases: potential therapeutic implications in a mouse model of hindlimb ischemia. Stem Cells, 28, 431-442.
82. Pesce, M., Burba, I., Gambini, E., et al. (2011). Endothelial and cardiac progenitors: boosting, conditioning and (re)programming for cardiovascular repair. Pharmacology and Therapeutics, 129, 50-61.
83. Burba, I., Colombo, G. I., Staszewsky, L. I., et al. (2011). Histone deacetylase inhibition enhances self renewal and cardioprotection by human cord blood-derived CD34 cells. PLoS One, 6, e22158.
84. Mottet, D., Bellahcene, A., Pirotte, S., et al. (2007). Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis. Circulation Research, 101, 1237-1246.
85. Margariti, A., Zampetaki, A., Xiao, Q. Z., et al. (2010). Histone deacetylase 7 controls endothelial cell growth through modulation of beta-catenin. Circulation Research, 106, 1202-U1275.
86. Zeng, L., Xiao, Q., Margariti, A., et al. (2006). HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. The Journal of Cell Biology, 174, 1059-1069.
87. Yamamoto, K., Takahashi, T., Asahara, T., et al. (2003). Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. Journal of Applied Physiology, 95, 2081-2088.
88. Illi, B., Scopece, A., Nanni, S., et al. (2005). Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Circulation Research, 96, 501-508.
89. Ohtani, K., Vlachojannis, G. J., Koyanagi, M., et al. (2011). Epigenetic regulation of endothelial lineage committed genes in pro-angiogenic hematopoietic and endothelial progenitor cells. Circulation Research, 109, 1219-U1271.
90. Collas, P., Noer, A., & Timoskainen, S. (2007). Programming the genome in embryonic and somatic stem cells. Journal of Cellular and Molecular Medicine, 11, 602-620.
91. Napoli, C., Glass, C. K., Witztum, J. L., et al. (1999). Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. The Lancet, 354, 1234-1241.
92. Weaver, I. C. G., Champagne, F. A., Brown, S. E., et al. (2005). Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: Altering epigenetic marking later in life. Journal of Neuroscience, 25, 11045-11054.
93. Bannister, A. J., & Kouzarides, T. (2005). Reversing histone methylation. Nature, 436, 1103-1106.
94. Weaver, I. C., Meaney, M. J., & Szyf, M. (2006). Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proceedings of the National Academy of Sciences of the United States of America, 103, 3480-3485.
95. Castro, R., Rivera, I., Struys, E. A., et al. (2003). Increased, homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clinical Chemistry, 49, 1292-1296.
96. Jiang, Y., Zhang, J., Xiong, J., et al. (2007). Ligands of peroxisome proliferator-activated receptor inhibit homocysteine-induced DNA methylation of inducible nitric oxide synthase gene. Acta Biochim Biophys Sin (Shanghai), 39, 366-376.
97. Chang, P. Y., Lu, S. C., Lee, C. M., et al. (2008). Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circulation Research, 102, 933-941.
98. Post, W. S., Goldschmidt-Clermont, P. J., Wilhide, C. C., et al. (1999). Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovascular Research, 43, 985-991.
99. Ying, A. K., Hassanain, H. H., Roos, C. M., et al. (2000). Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells. Cardiovascular Research, 46, 172-179.
100. Kim, J., Kim, J. Y., Song, K. S., et al. (2007). Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1772, 72-80.
101. Issa, J. P. (2000). CpG-island methylation in aging and cancer. DNA Methylation and Cancer, 249, 101-118.
102. Hiltunen, M. O., Turunen, M. P., Hakkinen, T. P., et al. (2002). DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vascular Medicine, 7, 5-11.
103. Laukkanen, M. O., Mannermaa, S., Hiltunen, M. O., et al. (1999). Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 2171-2178.
104. Hiltunen, M. O., & Yla-Herttuala, S. (2003). DNA methylation, smooth muscle cells, and atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 1750-1753.
105. Miranda, T. B., & Jones, P. A. (2007). DNA methylation: the nuts and bolts of repression. Journal of Cellular Physiology, 213, 384-390.
106. Lund, G., Andersson, L., Lauria, M., et al. (2004). DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. Journal of Biological Chemistry, 279, 29147-29154.
107. Zaina, S., Lindholm, M. W., & Lund, G. (2005). Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia? Journal of Nutrition, 135, 5-8.
108. Stenvinkel, P., Karimi, M., Johansson, S., et al. (2007). Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? Journal of Internal Medicine, 261, 488-499.
109. Kim, M., Long, T. I., Arakawa, K., et al. (2010). DNA Methylation as a biomarker for cardiovascular disease risk. Plos One, 5.
110. Wilson, V. L., & Jones, P. A. (1983). DNA methylation decreases in aging but not in immortal cells. Science, 220, 1055-1057.
111. Villeneuve, L. M., Reddy, M. A., Lanting, L. L., et al. (2008). Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proceedings of the National Academy of Sciences of the United States of America, 105, 9047-9052.
112. Reddy, M. A., Villeneuve, L. M., Wang, M., et al. (2008). Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice. Circulation Research, 103, 615-623.
113. Stolar, M. (2010). Glycemic control and complications in type 2 diabetes mellitus. American Journal of Medicine, 123, S3-S11.
114. Roy, S., Sala, R., Cagliero, E., et al. (1990). Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proceedings of the National Academy of Sciences of the United States of America, 87, 404-408.
115. Brasacchio, D., Okabe, J., Tikellis, C., et al. (2009). Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes, 58, 1229-1236.
116. El-Osta, A., Brasacchio, D., Yao, D., et al. (2008). Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. The Journal of Experimental Medicine, 205, 2409-2417.
117. Li, S. L., Reddy, M. A., Cai, Q., et al. (2006). Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice. Diabetes, 55, 2611-2619.
118. Hill, J. M., Zalos, G., Halcox, J. P., et al. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. The New England Journal of Medicine, 348, 593-600.
119. Vasa, M., Fichtlscherer, S., Aicher, A., et al. (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circulation Research, 89, E1-E7.
120. Werner, N., Kosiol, S., Schiegl, T., et al. (2005). Circulating endothelial progenitor cells and cardiovascular outcomes. The New England Journal of Medicine, 353, 999-1007.
121. De Falco, E., Avitabile, D., Totta, P., et al. (2009). Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus. Journal of Cellular and Molecular Medicine, 13, 3405-3414.
122. Loomans, C. J., van Haperen, R., Duijs, J. M., et al. (2009). Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia. Molecular Medicine, 15, 152-159.
123. Dimmeler, S., Aicher, A., Vasa, M., et al. (2001). HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. The Journal of Clinical Investigation, 108, 391-397.
124. Bertram, C., Khan, O., Ohri, S., et al. (2008). Transgenerational effects of prenatal nutrient restriction on cardiovascular and hypothalamic-pituitary-adrenal function. The Journal of Physiology, 586, 2217-2229.
125. Bygren, L. O., Kaati, G., & Edvinsson, S. (2001). Longevity determined by paternal ancestors' nutrition during their slow growth period. Acta Biotheoretica, 49, 53-59.
126. Lumey, L. H. (1998). Reproductive outcomes in women prenatally exposed to undernutrition: a review of findings from the Dutch famine birth cohort. Proceedings of the Nutrition Society, 57, 129-135.
127. Forsen, T., Eriksson, J. G., Tuomilehto, J., et al. (1999). Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. British Medical Journal, 319, 1403-1407.
128. Palinski, W., & Napoli, C. (2002). The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. The FASEB Journal, 16, 1348-1360.
129. Zambrano, E., Bautista, C. J., Deas, M., et al. (2006). A low maternal protein diet during pregnancy and lactation has sex- and window of exposure-specific effects on offspring growth and food intake, glucose metabolism and serum leptin in the rat. The Journal of Physiology, 571, 221-230.
130. Torrens, C., Hanson, M. A., Gluckman, P. D., et al. (2009). Maternal undernutrition leads to endothelial dysfunction in adult male rat offspring independent of postnatal diet. British Journal of Nutrition, 101, 27-33.
131. Sathishkumar, K., Elkins, R., Yallampalli, U., et al. (2009). Protein restriction during pregnancy induces hypertension and impairs endothelium-dependent vascular function in adult female offspring. Journal of Vascular Research, 46, 229-239.
132. Bogdarina, I., Welham, S., King, P. J., et al. (2007). Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circulation Research, 100, 520-526.
133. Sherman, R. C., & Langley-Evans, S. C. (1998). Early administration of angiotensin converting enzyme inhibitor captopril, prevents the development of hypertension programmed by intrauterine exposure to a maternal low-protein diet in the rat. Clinical Science, 94, 373-381.
134. Lillycrop, K. A., Phillips, E. S., Torrens, C., et al. (2008). Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPAR alpha promoter of the offspring. British Journal of Nutrition, 100, 278-282.
135. Lillycrop, K. A., Slater-Jefferies, J. L., Hanson, M. A., et al. (2007). Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. British Journal of Nutrition, 97, 1064-1073.
136. Das, S. K., & Chakrabarti, R. (2006). Role of PPAR in cardiovascular diseases. Recent Patents on Cardiovascular Drug Discovery, 1, 193-209.
137. Walker, B. R. (2007). Glucocorticoids and cardiovascular disease. European Journal of Endocrinology, 157, 545-559.
138. Lillycrop, K. A., Phillips, E. S., Jackson, A. A., et al. (2005). Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. Journal of Nutrition, 135, 1382-1386.
139. Terzolo, M., Allasino, B., Bosio, S., et al. (2004). Hyperhomocysteinemia in patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 89, 3745-3751.
140. Armitage, J. A., Lakasing, L., Taylor, P. D., et al. (2005). Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy. The Journal of Physiology, 565, 171-184.
141. Dunn, G. A., & Bale, T. L. (2009). Maternal high-fat diet promotes body length increases and insulin insensitivity in second-generation mice. Endocrinology, 150, 4999-5009.
142. Khan, I. Y., Dekou, V., Douglas, G., et al. (2005). A high-fat diet during rat pregnancy or suckling induces cardiovascular dysfunction in adult offspring. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 288, R127-R133.
143. Kiel, D. W., Dodson, E. A., Artal, R., et al. (2007). Gestational weight gain and pregnancy outcomes in obese women: how much is enough? Obstetrics and Gynecology, 110, 752-758.
144. Simmons, R. (2011). Epigenetics and maternal nutrition: nature v. nurture. Proceedings of the Nutrition Society, 70, 73-81.
145. Heerwagen, M. J., Miller, M. R., Barbour, L. A., et al. (2010). Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 299, R711-R722.
146. Ainge, H., Thompson, C., Ozanne, S. E., et al. (2011). A systematic review on animal models of maternal high fat feeding and offspring glycaemic control. International Journal of Obesity, 35, 325-335.
147. Wu, G., & Meininger, C. J. (2009). Nitric oxide and vascular insulin resistance. Biofactors, 35, 21-27.
148. Heijmans, B. T., Tobi, E. W., Stein, A. D., et al. (2008). Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proceedings of the National Academy of Sciences of the United States of America, 105, 17046-17049.
149. Tobi, E. W., Lumey, L. H., Talens, R. P., et al. (2009). DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Human Molecular Genetics, 18, 4046-4053.
150. Reik, W. (2007). Stability and flexibility of epigenetic gene regulation in mammalian development. Nature, 447, 425-432.
151. Nafee, T. M., Farrell, W. E., Carroll, W. D., et al. (2008). Epigenetic control of fetal gene expression. BJOG: An International Journal of Obstetrics and Gynaecology, 115, 158-168.
152. Branco, M. R., Oda, M., & Reik, W. (2008). Safeguarding parental identity: Dnmt1 maintains imprints during epigenetic reprogramming in early embryogenesis. Genes & Development, 22, 1567-1571.
153. Waterland, R. A., & Jirtle, R. L. (2004). Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition, 20, 63-68.
154. Waterland, R. A., Travisano, M., Tahiliani, K. G., et al. (2008). Methyl donor supplementation prevents transgenerational amplification of obesity. International Journal of Obesity, 32, 1373-1379.
155. Dolinoy, D. C., Weidman, J. R., Waterland, R. A., et al. (2006). Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environmental Health Perspectives, 114, 567-572.
156. Farthing, C. R., Ficz, G., Ng, R. K., et al. (2008). Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes. PLoS Genetics, 4, e1000116.
157. Kwong, W. Y., Miller, D. J., Ursell, E., et al. (2006). Imprinted gene expression in the rat embryo-fetal axis is altered in response to periconceptional maternal low protein diet. Reproduction, 132, 265-277.
158. Watkins, A. J., Wilkins, A., Cunningham, C., et al. (2008). Low protein diet fed exclusively during mouse oocyte maturation leads to behavioural and cardiovascular abnormalities in offspring. The Journal of Physiology, 586, 2231-2244.
159. Shao, W. J., Tao, L. Y., Gao, C., et al. (2008). Alterations in methylation and expression levels of imprinted genes H19 and Igf2 in the fetuses of diabetic mice. Comparative Medicine, 58, 341-346.
160. Doherty, A. S., Mann, M. R., Tremblay, K. D., et al. (2000). Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biology of Reproduction, 62, 1526-1535.
161. Khosla, S., Dean, W., Brown, D., et al. (2001). Culture of preimplantation mouse embryos affects fetal development and the expression of imprinted genes. Biology of Reproduction, 64, 918-926.
162. Cox, G. F., Burger, J., Lip, V., et al. (2002). Intracytoplasmic sperm injection may increase the risk of imprinting defects. American Journal of Human Genetics, 71, 162-164.
163. DeBaun, M. R., Niemitz, E. L., & Feinberg, A. P. (2003). Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. American Journal of Human Genetics, 72, 156-160.
164. Lieb, J. D., Beck, S., Bulyk, M. L., et al. (2006). Applying whole-genome studies of epigenetic regulation to study human disease. Cytogenetic and Genome Research, 114, 1-15.
165. Kim, T. H., Barrera, L. O., Zheng, M., et al. (2005). A high-resolution map of active promoters in the human genome. Nature, 436, 876-880.